SIGYN THERAPEUTICS, INC. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/bfcef037-c399-4299-904c-56ef4d438cb3/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-2.5M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-004740 |
| FY 2023 | $-2.5M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-007240 |
| FY 2022 | $-2.1M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009883 |
| FY 2021 | $-2.0M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-007382 |
| FY 2020 | $-916.4k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008047 |
| FY 2019 | $-518.0k | 2019-01-01 – 2019-12-31 | evidence 0001753926-20-000068 |
| FY 2018 | $-1.0M | 2018-01-01 – 2018-12-31 | evidence 0001615774-19-005117 |
| FY 2017 | $-2.0M | 2017-01-01 – 2017-12-31 | evidence 0001615774-19-005117 |
| FY 2015 | $-2.3M | 2015-01-01 – 2015-12-31 | evidence 0001615774-16-004714 |
| FY 2014 | $-387.5k | 2014-01-01 – 2014-12-31 | evidence 0001615774-16-004714 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).